Artivion

Yahoo Finance • 9 days ago

Artivion price target raised to $45 from $32 at Needham

Needham analyst Mike Matson raised the firm’s price target on Artivion (AORT) to $45 from $32 and keeps a Buy rating on the shares. The company’s constant currency revenue growth improved to 14.6% in Q2 from 3.6% in Q1, driven by strong On... Full story

Yahoo Finance • 10 days ago

Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth

Earnings Call Insights: Artivion, Inc. (AORT) Q2 2025 MANAGEMENT VIEW * CEO Pat MacKin reported "strong business momentum continued through the second quarter as we delivered total constant currency revenue growth of over 14% and adjus... Full story

Yahoo Finance • 10 days ago

Artivion stock price target raised to $41 from $35 at Canaccord on strong Q2

Investing.com - Canaccord Genuity raised its price target on Artivion Inc. (NYSE:AORT) to $41.00 from $35.00 on Friday, maintaining a Buy rating following the company’s strong second-quarter performance. The medical device company, with a... Full story

Yahoo Finance • 28 days ago

[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately U... Full story

Yahoo Finance • last month

Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • last month

Artivion Inc stock reaches 52-week high at 32.38 USD

Artivion Inc’s stock has reached a 52-week high, hitting 32.38 USD, marking a significant milestone for the $1.51 billion market cap company. According to InvestingPro analysis, the stock appears to be trading above its Fair Value, with an... Full story

Yahoo Finance • 2 months ago

Canaccord Genuity initiates Artivion stock with buy rating on aortic repair bets

Canaccord Genuity initiated coverage on Artivion Inc. (NYSE: AORT) with a buy rating and a $35.00 price target on Tuesday. The research firm cited the cardiac surgery company’s strategic investments in aortic arch repair that are "on the v... Full story

Yahoo Finance • 2 years ago

Artivion to Participate in Upcoming Investor Conferences

ATLANTA, Nov. 8, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. (PRNewsfoto/Artivio... Full story